Relay Therapeutics, Inc.
RLAY· Nasdaq
RLAYRelay Therapeutics, Inc.
Filed Aug 12, 2021 · 10-Q · 43 days after period end · 0001564590-21-043999
| Metric | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|
| Revenue | $844.00K | — | — |
| Net Income | -$193.40M | -$26.72M | -$17.54M |
| EPS Diluted | -$2.10 | -$6.06 | -$5.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end
